Sourced from:Manufacturer Authorized Distributor
Quick Summary
Pacliage 30mg Injection
Last updated on 31 Mar 2026 | 09:29 AM (IST)
₹430
MRP: ₹1129
(You Save ₹699)
1 VIAL(s)
Sourced from:Manufacturer Authorized Distributor
62% OFF
₹430
MRP: ₹1,129.00
Inclusive of all taxes
62% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Kansure 30mg Injection
KHANDELWAL LABO...
₹ 287.00/injection
33% cheaper
Paclitero 30mg Injection
HETERO HEALTHCA...
₹ 340.00/injection
20% cheaper
Taxeleon 30mg Injection
NEON LABORATORI...
₹ 366.00/injection
14% cheaper
Pacliarc 30mg Injection
DELARC PHARMACE...
₹ 375.00/injection
12% cheaper
Introduction to Pacliage 30mg Injection
Pacliage 30mg Injection is a chemotherapy medication containing the active constituent paclitaxel. It is used to treat breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is a condition in which cells are dividing and growing fast and in an uncontrolled manner. This medicine is not recommended for adolescents and children under the age of 18.
Pacliage 30mg Injection may be given alone or in combination with other anticancer medicines. This chemotherapy medication is contraindicated in patients with severe liver problems, uncontrolled infection, and low white blood cell or platelet count. Talk to your doctor if you have heart disorders before taking this medicine.
Administration of this medicine may cause serious allergic reactions. Use effective birth control during the treatment and for at least six months after the last dose. Pacliage 30mg Injection may be harmful to the patients suffering from alcoholism as this medicine contains alcohol.
Uses of Pacliage 30mg Injection
Pacliage 30mg Injection is used in the treatment of the following:
- Ovarian cancer
- Breast cancer
- Non-small cell lung cancer
- AIDS-related Kaposi’s sarcoma
Therapeutic Effects of Pacliage 30mg Injection
Pacliage 30mg Injection inhibits the microtubule structures present in the cell. Microtubule structures help cancer cells to divide and multiply. Inhibition of these structures slows the growth of cancer cells.
Interaction of Pacliage 30mg Injection with other drugs
Inform your doctor about any medications you are taking or have taken before the treatment.
More Information about Pacliage 30mg Injection
- Keep Pacliage 30mg Injection out of sight and reach of children.
- Do not store above 25°C.
How to consume Pacliage 30mg Injection
It will be given to you by a doctor or nurse in a healthcare setting.
Safety Advice for Pacliage 30mg Injection
Breast Feeding
Stop breastfeeding during the treatment with Pacliage 30mg Injection. Consult your doctor for potential risks.
Alcohol
It is unsafe to consume alcohol with Pacliage 30mg Injection.
Liver
It is contraindicated in patients with severe liver disorders. Inform your doctor if you have any liver disorders before taking Pacliage 30mg Injection.
Lungs
It is unknown whether Pacliage 30mg Injection can be given to patients with lung disorders. Please consult your physician for more advice.
Driving
The alcohol present in Pacliage 30mg Injection may affect your ability to drive. Avoid driving if you feel unwell.
Pregnancy
Pacliage 30mg Injection can harm your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking Paclitaxel Injection.
Side Effects of Pacliage 30mg Injection
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious side effects of Pacliage 30mg Injection are:
- Serious allergic reactions (rash, swelling of face, lips, throat, or tongue, trouble breathing, and swallowing)
- Severe diarrhoea
- Severe stomach pain
Common side effects of Pacliage 30mg Injection are:
- Anemia, feeling tired
- Hair loss
- Burning, tingling, or numbness in your feet or hands
- Muscle and joint pain
- Vomiting, nausea
- Mouth or lip sores
- Infections
- Swelling of hands, feet, and face
- Bleeding
- Irritation at the injection site
- Low blood pressure
Word of Advice
Inform the doctor if the patient is allergic to this medication, liver, heart conditions and other medication taken for different medical conditions before taking this medicine. Liver, blood pressure, blood count should be monitored while taking this medication. Don't take this medication if the patient is planning for pregnancy or during pregnancy and in breast feeding mothers as it causes harmful effects on developing babies. Avoid driving and handling heavy machinery after taking this medication as it can affect the concentration and alertness.
FAQs about Pacliage 30mg Injection
Q1.
Can Pacliage 30mg Injection cause hair loss?
Yes, the common side effects of this medication is hair loss and inform the doctor if there is excessive hair loss.
Q2.
Can I take Pacliage 30mg Injection during pregnancy?
It is unsafe to take this medication during pregnancy as it causes harmful effects in the developing baby. Inform the doctor if the patient is planning for pregnancy before starting this medication.
Q3.
What are the side effects of Pacliage 30mg Injection?
The common side effects of this medication are anaemia, hair loss, numbness in feet or hands, muscle pain, nausea, vomiting, infections, swelling, bleeding, irritation on the injection site, and low blood pressure.
Q4.
Can I take Pacliage 30mg Injection while driving?
It is unsafe to use this medication while driving because it can cause dizziness, lack of concentration and alertness.
Q5.
Does Pacliage 30mg Injection cause liver problems?
Yes, this medication is contraindicated in patients with severe liver disorders. Inform the doctor before starting this medication.
Q6.
How does Pacliage 30mg Injection work?
It works by interfering with the microtubule structures which help the cancer cells to divide and multiply and it slows the growth of cancer cells.
Fact Box of Pacliage 30mg Injection
Molecule name: Paclitaxel | Pharmacological class: Anti-Microtubular Agents |
Therapeutic class: Anti-neoplastics | Indications: 1. Ovarian cancer 2. Breast cancer 3. Non-small cell lung cancer 4. AIDS-related Kaposi’s sarcoma |
References
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1707 - 1709.
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 865.
- Hospira UK Limited, Electronic medicines compendium (emc), [ Revised on March 2020] [ Accessed on 22nd June 2021], https://www.medicines.org.uk/emc/files/pil.3891.pdf
- Bristol-Myers Squibb Company, US Food and Drug Administration, [ Revised on April 2011] [ Accessed on 22nd June 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020262s049lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get accurate and trustworthy information that is reviewed by experts. The contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Vijayalakshmi N.
BDS
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:29 AM (IST)
Want to know more?
Read Our Editorial Policy
